Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BCDIN3 domain containing RNA methyltransferase (BCDIN3D) is an enzyme of the Rossmann fold methyltransferase family that functions mainly as a 5'-methylphosphate capping enzyme for cytoplasmic histidyl tRNA (tRNA(His))[1][2][5]. By using S-adenosylmethionine as a methyl donor, it monomethylates the 5'-monophosphate of tRNA(His), a modification that protects the tRNA from degradation. BCDIN3D can also methylate the 5'-monophosphate of some precursor microRNAs (pre-miRNAs), acting as a negative regulator of miRNA processing, by interfering with Dicer-mediated cleavage and maturation—this mechanism appears particularly important in cancer cells, such as breast cancer, in which BCDIN3D is overexpressed and is associated with tumor invasiveness and poor prognosis. It may thus play roles in tumorigenesis through post-transcriptional regulation of gene expression[1][2][3][5].
BCDIN3D inhibits 5'-monophosphate methylation of tRNA(His) or pre-miRNAs, and modulates miRNA biogenesis by methylating precursor miRNAs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BCDIN3 domain containing RNA methyltransferase (BCDIN3D).